Oncolytics Biotech
ONCY
$1.18
Share price
1.72%
Change (1 day)
-30.99%
Change (1 year)
Categories
Oncolytics Biotech (ONCY) - Total debt
Total debt on the balance sheet as of December 2023 : $0.31 M
According to Oncolytics Biotech 's latest financial reports the company's total debt is $0.31 M. A company’s total debt is the sum of all current and non-current debts.
Oncolytics Biotech - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.31 M | 15.88% |
| 2022-12-31 | $0.27 M | -46.35% |
| 2021-12-31 | $0.51 M | 62.99% |
| 2020-12-31 | $0.31 M | -18.65% |
| 2019-12-31 | $0.38 M | |
| 2018-12-31 | $N/A | |
| 2006-12-31 | $0.12 M | 0.06% |
| 2005-12-31 | $0.12 M | 3.1% |
| 2004-12-31 | $0.12 M | 8% |
| 2003-12-31 | $0.11 M | 5.5% |
| 2002-12-31 | $0.1 M | 0% |
| 2001-12-31 | $0.1 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $26.21 B | 8,203,627.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 17,967,950.68% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | $50.22 M | 15,618.95% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $0.27 M | -12.68% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 6,307,449.78% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | $38.68 M | 12,006.19% | 🇺🇸 USA |